CSL
CSL1 was a randomized clinical trial where, in the period 1962-69, 488 patients with liver cirrhosis were treated with either the active drug prednisone (251 patients) or placebo (237 patients). The purpose of the trial was to evaluate the effect of treetment on survival. After randomization patients were followed to either death, drop-out or end of study (September 1974): 142 prednisone patients and 150 placebo patients died. The survival times for the remaining patients are right-censored. The data file includes the following variables: ID = patient id. (integer, range 1-561) DC = 1, if failure 0, if censoring DAYS = survival time in days from randomization TMENT = 0, if prednisone 1, if placebo SEX = 0, if female, 1, if male ASC = 0, if no ascites, 1, if some, 2, if moderate or marked AGE (in years, range 17-80) PRO(thrombin) (in % of normal, range 12-135) ACE(tylcholinesterase) (in micromoles/min/ml, range 26-659) INFL(ammation in liver connective tissue) = 0, if none, 1, if slight, 2, if moderate, 3, if severe
The dataset
Scripts for loading the dataset
Programs related to CSL
Table 1.5.2: R-source SAS-source (tab-csl-ch1ascbeh) | |
Table 5.2.7: R-source SAS-source (tab-csl-ch5ascbeh-nointeract) | |
Table 5.2.8: R-source SAS-source (tab-csl-ch5ascbeh-interact1) | |
Table 5.2.9: R-source SAS-source (tab-csl-ch5ascbeh-interact2) | |
Table 5.2.10: R-source SAS-source (tab-csl-ch5ascbeh-tests) | |
Table 5.2.14: R-source SAS-source (tab-csl-ch5ascbeh-interact3) | |
Table 5.3.2: R-source SAS-source (tab-ch5-3wayinter-est) | |
Table 5.3.3: R-source SAS-source (tab-ch5-treatmenteffects) |